A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

C. Duran; A. Burbank; K. Mills; H. Duckworth; M. Aleman; Matthew Kesic; D. Peden; Y. Pan; H. Zhou; M. L. Hernandez

doi:10.1186/s12931-016-0406-8

A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

C. Duran
, A. Burbank
, K. Mills
, H. Duckworth
, M. Aleman
, Matthew Kesic
, D. Peden
, Y. Pan
, H. Zhou
, M. L. Hernandez

Campbell University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Respiratory Research
Volume	17
DOIs	https://doi.org/10.1186/s12931-016-0406-8
State	Published - Jul 22 2016

Disciplines

Medicine and Health Sciences

Access to Document

10.1186/s12931-016-0406-8License: Unspecified

A proof-of-concept clinical study examining the NRF2 activator suFinal published version, 489 KBLicense: Unspecified

Cite this

@article{afb1b8f4291747e9b6854e1777664cec,

title = "A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation",

author = "C. Duran and A. Burbank and K. Mills and H. Duckworth and M. Aleman and Matthew Kesic and D. Peden and Y. Pan and H. Zhou and Hernandez, \{M. L.\}",

year = "2016",

month = jul,

day = "22",

doi = "10.1186/s12931-016-0406-8",

language = "American English",

volume = "17",

journal = "Respiratory Research",

}

TY - JOUR

T1 - A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

AU - Duran, C.

AU - Burbank, A.

AU - Mills, K.

AU - Duckworth, H.

AU - Aleman, M.

AU - Kesic, Matthew

AU - Peden, D.

AU - Pan, Y.

AU - Zhou, H.

AU - Hernandez, M. L.

PY - 2016/7/22

Y1 - 2016/7/22

UR - https://cufind.campbell.edu/physician_assistant_program/72

U2 - 10.1186/s12931-016-0406-8

DO - 10.1186/s12931-016-0406-8

M3 - Article

VL - 17

JO - Respiratory Research

JF - Respiratory Research

ER -

A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

Disciplines

Access to Document

Other files and links

Cite this